NewsPronto

 
Men's Weekly

.

ACN Newswire

Read more press releases from ACN Newswire here

Transgene, NEC and BostonGene Announce Strategic Collaboration for Two Ongoing Clinical Trials for Patients with Ovarian and Head Neck Cancers

  • Written by ACN Newswire

image

TOKYO, Oct 6, 2020 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, NEC Corporation (TSE: 6701), a leader in IT and network technologies, and BostonGene Corporation (BostonGene), a biomedical software company committed to defining optimal...

Read more: Transgene, NEC and BostonGene Announce Strategic Collaboration for Two Ongoing Clinical Trials for...